Kidney transplantation in patients with sickle cell disease

Dialysis and Transplantation

Volumn 26, Issue 9, 1997, Pages 606-611

  Ribot, Seymour ^a  

^a NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 6044239539     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kariske BL, Ramos EL, Gaston RS, et al. The evaluation of renal transplant candidates: Clinical practice guidelines. J Am Soc Nephrol 1995; 6:1-34.
2. Barber WH, Deierhoe MH, Julian BA, et al. Renal transplant in sickle cell anemia and sickle cell disease. Clin Transpl 1987; 1:169-175
3. Chatterjee SN. National study on natural history of renal allografts in sickle cell disease or trait. Nephron 1980; 25:199-201.
4. Platt OS, Brambilla DJ, Rosse WF, et al. Life expectancy and risk factors for early death in sickle ceil disease. N Engl J Med 1994, 330:1639-1644.
5. Powars DR, Elliot-Mills DD, Chan L, et al. Chronic renal failure in sickle cell disease: Risk factors, clinical course and mortality. Ann Intern Med 1991; 115 614-620.
6. Montgomery R, Ziban G, Hill GS, et al Renal transplantation in patients with sickle cell nephropathy. Transplantation 1994, 58 618-620.
7. Charterjee SN. National study in natural history of renal allografts in sickle cell disease or trait: A second report Transplant Proc 1987; 19(Suppl 2).33-35.
8. Specter D, Zachary JB, Sterioff S, et al. Painful cnses following renal transplantation in sickle cell anemia. Am J Med 1978; 64-835-839.
9. Miner DJ, Jorkasky DK, Perloff LJ, et al. Recurrent sickle cell nephropathy in a transplanted kidney. Am J Kidney Dis 1987; 10:306-313.
10. Chatterjee SN, Lundberg GD, Berne TV. Sickle cell trait: Possible contributory cause of renal allograft failure. Urology 1978; 11:266-268.
11. Bhathena DB, Sondheimer JH. The glomerulopathy of homozygous sickle hemoglobin (SS) disease: Morphology and pathogenesis. J Am Soc Neph 1991; 11:1241-1252
12. Ramos EL, Tisher CC. Recurrent disease in the kidney transplant. Am J Kidney Dis 1994; 24:142-154.
13. Opelz G, Terasaki PI. Dominant effect of transfusions on kidney graft survival. Transplantation 1980; 29:153-158.
14. Opelz G, Terasaki PI. Improvement of kidney graft survival with increased numbers of blood transfusions. N Engl J Med 1978; 299:799-803.
15. Thuraisingham RC, Roger SD, MacDougall IC, et al. Improvement in anemia following renal transplantation but not after erythropoietin therapy in a patient with sickle cell disease. Nephrol Dial Transplant 1993; 8:371-372
16. Silliman CC, Peterson VM, Mellman DL, et al. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: A randomized, double-blind study of the dose-response relationship. J Lab Clin Med 1993; 122:48-54.
17. Collins AF, Fassos FF, Stobie S, et al. Iron balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4 one (L1) in iron loaded patients with sickle cell disease. Blood 1994; 83:2329-2333.
18. Haddy TB, Casto O Overt iron deficiency in sickle cell disease. Arch Intern Med 1982; 142:1621-1624.
19. Bowden RA, Slichter SJ, Savers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995; 86:3599.
20. Hillyer CD, Emmens RK, Zago-Novaretti M, et al Methods for reduction of transfusion-transmitted cytomegalovirus infection Filtration versus the use of seronegame donor units. Transfusion 1994; 34.929
21. Goldberg MA, Brugman C, Dover GJ, et al. Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl J Med 1990; 323.366.
22. Rogers GP, Dover GJ, Noguchi CT, et al. Hematologic response of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med 1990, 322.103